Pathophysiology of Respiratory Conditions: Pneumothorax, Atelectasis, and ARDS

Exam Tip: If you see a patient with tracheal deviation away from the affected side, hypotension, and absent breath sounds on one side, suspect a Tension Pneumothorax immediately.

Atelectasis: Alveolar Collapse and V/Q Mismatch

Atelectasis is the collapse of lung tissue, which prevents the alveoli from participating in gas exchange. This collapse results in a V/Q mismatch (ventilation/perfusion mismatch), where blood flows past non-ventilated alveoli, leading to hypoxemia.

Atelectasis can be categorized by its mechanism:

1. Obstructive: Air is absorbed from alveoli that have become blocked (e.g., by mucus or a tumor).
2. Compression: External pressure from a tumor, fluid, or abdominal distention pushes against the lung tissue.

Surfactant impairment is a major contributor to atelectasis, particularly in post-surgical patients. Pain often leads to shallow breathing; this lack of deep inspiration causes secretions to pool, obstructing small airways and reducing the production or effectiveness of surfactant. Clinical signs include diminished breath sounds, crackles, and decreased $SpO_2$.

Acute Respiratory Distress Syndrome (ARDS)

ARDS is a severe form of respiratory failure characterized by acute lung inflammation and diffuse alveolocapillary injury. Unlike heart failure, ARDS causes non-cardiogenic pulmonary edema, meaning the fluid buildup in the lungs is caused by damaged capillary membranes rather than high pressure from the heart.

The Three Phases of ARDS

The progression of ARDS is typically divided into three distinct phases:

1. Exudative Phase (within 72 hours): An initial injury (such as sepsis or pneumonia) triggers an inflammatory response where neutrophils flood the lungs. These cells release inflammatory mediators and free radicals that damage the alveolocapillary membrane, making it "leaky". Protein-rich fluid fills the interstitium and alveoli, and damage to Type II cells leads to surfactant loss and subsequent atelectasis.
2. Proliferative Phase (days 4–21): Inflammation continues, and the body attempts to repair the damage, often resulting in the formation of hyaline membranes—thick layers of protein and dead cells that line the alveoli.
3. Fibrotic Phase (days 14–21): In many patients, the lung tissue undergoes permanent scarring and stiffening, which significantly decreases lung compliance.

Refractory Hypoxemia

A hallmark clinical finding in ARDS is refractory hypoxemia. This occurs when blood is shunted past non-functional, fluid-filled, or collapsed alveoli. In these cases, increasing the concentration of supplemental oxygen does not significantly improve the patient's $PaO_2$ because the oxygen cannot reach the blood through the damaged alveolar-capillary interface.

Clinical Note: Treatment for ARDS is intensive and focuses on mechanical ventilation with PEEP (Positive End-Expiratory Pressure) to keep alveoli open, prone positioning to improve ventilation-perfusion matching, and treating the underlying cause, such as sepsis.